Opicinumab Uses, Dosage, Side Effects and more
Opicinumab is under investigation in clinical trial NCT02641041 (Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants).
| Trade Name | Opicinumab |
| Generic | Opicinumab |
| Opicinumab Other Names | Opicinumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
